
CoraDoc Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: prepaying for a longer compounded GLP-1 program at a low monthly rate
CoraDoc scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
CoraDoc is a Dallas-based telehealth service selling compounded semaglutide and tirzepatide as prepaid, one-payment programs with no subscription or auto-renew. Plans run from a 6-week starter ($299 semaglutide, $399 tirzepatide) to 12 months ($924, about $77/mo, or $1,524, about $127/mo), at the same price for every dose. The provider visit, 2-day shipping, and supplies are included, and maintenance plans serve current GLP-1 users. Its refund policy keeps a $100 clinical fee if you are not prescribed.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to CoraDoc
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
CoraDoc at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $217/mo (see plan details)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored CoraDoc
Each dimension is scored algorithmically from CoraDoc’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $217/mo (see plan details), CoraDoc runs about 19% above the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10CoraDoc offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.8/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.9/10CoraDoc's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.3/10CoraDoc provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this CoraDoc review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $217–$289/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with CoraDoc
We walked CoraDoc’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a GLP-1 program (new patient or maintenance) and a plan length on the product page: 6 weeks, 3, 6, or 12 months.
- 2An optional peptide add-on screen (NAD+, sermorelin, B12, glutathione) appears next and can be skipped.
- 3An optional supplements screen follows and can also be skipped.
- 4Checkout asks for name, address, phone, email, date of birth, and card payment before any medical intake; we stopped here.
- Every plan length and its total is shown on the product page, and the cart matched it ($299 for the 6-week semaglutide starter, free shipping).
- Payment is collected at checkout before the health intake and provider review.
- Peptide and supplement upsell screens sit between plan choice and checkout, though both have a skip button.
- Product pages promise a full refund if not approved, while the refund policy keeps a $100 clinical service fee.
- The general Get Started path opens with a BMI-range question before plan selection.
CoraDoc customer support
- Phone
- 855-983-5336
- careteam@coradoc.com
- Hours
- 9am-7pm CST
GLP-1 medications CoraDoc offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$299 one-time for 6 weeks, no auto-renew. Longer plans: 3-mo $495 ($165/mo), 6-mo $522 ($87/mo), 12-mo $924 ($77/mo), each paid once.
$399 one-time for 6 weeks, no auto-renew. Longer plans: 3-mo $695 ($232/mo), 6-mo $822 ($137/mo), 12-mo $1,524 ($127/mo), each paid once.
Ready to get started?
Plans and promotions change often, so check CoraDoc's current pricing and active discounts before you decide.
What we like
- Long plans are cheap: 12 months of compounded semaglutide for $924 (about $77/mo) or tirzepatide for $1,524 (about $127/mo)
- One payment with no subscription or auto-renew, and the price does not rise as your dose goes up
- Provider visit, 2-day shipping, and injection supplies are included at no extra cost
- Shows a LegitScript seal and names its pharmacy partner (DIRX) and a Dallas, TX address
- Phone support with real people, plus HSA/FSA, Afterpay, Klarna, and Affirm
Watch-outs
- The shortest plan is a 6-week starter at $299 (semaglutide) or $399 (tirzepatide), paid upfront
- The lowest monthly rates require prepaying 6 or 12 months in a single charge
- Ads promise a full refund if you're not approved, but the refund policy keeps a $100 clinical fee
- No refunds once medication has been prescribed, compounded, or shipped
- The legal operating entity is not clearly named
Is CoraDoc worth it?
CoraDoc's whole pitch comes down to this: prepaying for a longer compounded GLP-1 program at a low monthly rate. It runs $217/month (see plan details) at every dose; there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
Beyond the medication itself, CoraDoc charges the same price at every dose. It also is LegitScript-certified and takes HSA/FSA payment.
How much CoraDoc costs
Compounded semaglutide runs $217/month (see plan details) and compounded tirzepatide runs $289/month (see plan details).
Because CoraDoc's headline figure is listed as “see plan details”, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare CoraDoc with the month-to-month prices of the alternatives below instead.
For a direct comparison, Belle Health runs semaglutide and tirzepatide from $199/month, so compare it with CoraDoc before you commit.
Medications: what CoraDoc prescribes
CoraDoc prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who CoraDoc is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
CoraDoc is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
CoraDoc scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with CoraDoc?
From $217/mo (see plan details). See current pricing and start your free consultation.
CoraDoc might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare CoraDoc vs…
CoraDoc scores7.7/10
Side-by-side pricing, medications and scores. Pick a matchup.
CoraDoc vs Amazon One Medical
Amazon One Medical scores 8.5/10

CoraDoc vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this CoraDoc review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See CoraDoc's current pricing
Plans from $217/mo (see plan details). Start your free consultation to check eligibility and today's price.